Efficacy and safety of direct-acting antiviral agents when combined with secukinumab
{{output}}
Background: The interference in the immune response induced by biological disease-modifying antirheumatic drugs (bDMARDs) increases the risk of reactivation of infections. Treatment of patients with chronic hepatitis C virus (HCV... ...
